Joseph Pategou on Muck Rack

Joseph Pategou

As seen in: Pharmaceutical Online, Drug Discovery & Development, Clinical Leader, Life Science Leader, Bioprocess Online, Outsourced Pharma, Cell & Gene, Biosimilar Development, Clinical Supply Leader
Healthcare
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joseph

Contact Joseph, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Rise Of AI-Powered Drones In Clinical Logistics And Supply Chains

|
By Joseph Pategou
| Clinical Supply Leader
By Joseph Pategou Clinical trial logistical challenges - including delays in drug distribution and compromised biological samples due to improper storage - pose significant barriers to accessing care and advancing therapies. The World Health Organization (WHO) estimates that at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified, resulting in $30.5 billion in annual losses. This highlights the urgent need for more efficient and reliable medical supply chains.
Open in Who Shared Issue with article?

Corporate Spin-Offs And NewCos: Unlocking Value in Biopharma Innovation

|
By Joseph Pategou
| Life Science Leader Verified
Guest Column | December 2, 2025 By Joseph Pategou Empirical research comparing corporate and academic spin-offs consistently shows that corporate-originated ventures outperform their academic counterparts in terms of growth and survival. This advantage is largely driven by more mature assets, stronger operational infrastructure, and clearer commercial pathways, enabling faster execution and higher rates of success.
Open in Who Shared Issue with article?

Small Molecule Pharma Companies Are Employing These Advanced Technologies To Get Ahead Original

|
By Joseph Pategou
| Pharmaceutical Online Verified
By Joseph Pategou Small molecule therapeutics account for over 50 percent of global pharmaceutical sales and nearly 70 percent of new FDA approvals in recent years, underscoring their continued dominance in medicine delivery.1 Every day, millions rely on small molecule medicines — yet few appreciate the sophisticated processes ensuring each pill’s safety and efficacy.
Open in Who Shared View Duplicates (2) Issue with article?
See all 26 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified